Venetoclax: evidence to date and clinical potential
The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are now more and more being replaced by targeted therapies due to superior efficacy and better safety profiles. However, evolution and selection of...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2019-10-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/venetoclax:-evidence-to-date-and-clinical-potential/ |